In California, faceoff between major insurer and health system shows hazards of consolidation

For weeks, more than half a million Anthem Blue Cross enrollees who receive health care from the University of California were held in suspense.

Ideaya showcases proof-of-concept data in a boost to synthetic lethality play

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

July 9, 2024

FDA approves Lumicell’s breast cancer imaging tool

Dive Brief: The Food and Drug Administration approved Lumicell’s breast cancer imaging tool, the company said Thursday. Lumicell developed the Lumisystem imaging technology to enable surgeons

April 22, 2024

Common inflammation pathway turns anthrax toxin into killer

Bacillus anthracis lethal toxin (LT) is a determinant of lethal anthrax. Its function in myeloid cells is required for bacterial dissemination, and LT itself can

December 26, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.